Thoracic radiotherapy variables: influence on local control in small cell lung cancer limited disease.

Limited small cell lung cancer: the effect of radiotherapy on local control following response to chemotherapy.

Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences.

Twice daily thoracic irradiation for limited small cell lung cancer.

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer.

Local control and lethal toxicity in limited small cell lung cancer.

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?

Small-cell lung cancer: local therapy for a systemic disease?

Role of thoracic radiotherapy in limited-stage small-cell lung cancer: quantitative review based on the literature versus meta-analysis based on individual data.

$A phase I study of split-dose cisplatin and etoposide with concurrent accelerated hyperfractionated thoracic radiotherapy in elderly patients with limited-disease small cell lung cancer.$
A phase I study of split-dose cisplatin and etoposide with concurrent accelerated hyperfractionated thoracic radiotherapy in elderly patients with limited-disease small cell lung cancer.

Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non-Small-Cell Lung Cancer.

Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.

Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer.

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.

Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase.

carboplatin chemotherapy for limited-disease small-cell lung cancer.

Local failure in patients treated with radiotherapy and multidrug chemotherapy for small cell lung cancer.

Radical thoracic radiotherapy may provide favorable outcomes for stage IV non-small cell lung cancer.

Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status.

Which patients with extensive stage small-cell lung cancer should and should not receive thoracic radiotherapy?

A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

Timing of thoracic irradiation in limited stage small-cell lung cancer: is it still a star on the rise?

Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy.

Suggest Documents

Limited small cell lung cancer: the effect of radiotherapy on local control following response to chemotherapy.

Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences.

Twice daily thoracic irradiation for limited small cell lung cancer.

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer.

Local control and lethal toxicity in limited small cell lung cancer.

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?

Small-cell lung cancer: local therapy for a systemic disease?

Role of thoracic radiotherapy in limited-stage small-cell lung cancer: quantitative review based on the literature versus meta-analysis based on individual data.

A phase I study of split-dose cisplatin and etoposide with concurrent accelerated hyperfractionated thoracic radiotherapy in elderly patients with limited-disease small cell lung cancer.

Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non-Small-Cell Lung Cancer.

Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.

Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer.

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.

Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase.

carboplatin chemotherapy for limited-disease small-cell lung cancer.

Local failure in patients treated with radiotherapy and multidrug chemotherapy for small cell lung cancer.

Radical thoracic radiotherapy may provide favorable outcomes for stage IV non-small cell lung cancer.

Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status.

Which patients with extensive stage small-cell lung cancer should and should not receive thoracic radiotherapy?

A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

Timing of thoracic irradiation in limited stage small-cell lung cancer: is it still a star on the rise?

Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy.

Thoracic radiotherapy variables: influence on local control in small cell lung cancer limited disease.

Recommend Documents

Follow Us